Gilead Sciences, Inc.GILDNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank14
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P14
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -3.72% |
| 2024 | 3.31% |
| 2023 | 14.89% |
| 2022 | 8.17% |
| 2021 | -8.69% |
| 2020 | 24.27% |
| 2019 | 3.44% |
| 2018 | 4.98% |
| 2017 | -26.76% |
| 2016 | 69.14% |